Nivestym 300 ug/.5mL

Nivestym 300 ug/0.5mL is a subcutaneous injection solution containing filgrastim-aafi. It is used to stimulate the production of white blood cells, often following chemotherapy or bone marrow transplantation. This medication is manufactured by Pfizer Laboratories.

Nivestym is primarily used to help the body produce more white blood cells. This is particularly important for individuals undergoing treatments that may reduce white blood cell counts, such as chemotherapy or bone marrow transplants. The active ingredient, filgrastim-aafi, works by stimulating the bone marrow to produce more of these essential cells, aiding in the recovery process.

Common effects of Nivestym may include mild to moderate pain or swelling at the injection site. Some individuals might experience bone pain, headaches, or fatigue. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Nivestym should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed guidelines for subcutaneous injection. Individuals with a history of allergic reactions to filgrastim or similar products should consult their healthcare provider before use.

Nivestym may interact with other medications, particularly those that affect the immune system. It is advisable to inform your healthcare provider about all current medications, including over-the-counter drugs and supplements. Alcohol and certain foods may also interact with Nivestym, so it is important to discuss any dietary considerations with a healthcare professional.